The Association between a Decrease in On-Treatment Neutrophil-to-Eosinophil Ratio (NER) at Week 6 after Ipilimumab Plus Nivolumab Initiation and Improved Clinical Outcomes in Metastatic Renal Cell Carcinoma.
- DOI
- 10.3390/cancers14153830
- Published
- 2022 Aug 7
- Container
- Cancers
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/cancers14153830,
title = {The Association between a Decrease in On-Treatment Neutrophil-to-Eosinophil Ratio (NER) at Week 6 after Ipilimumab Plus Nivolumab Initiation and Improved Clinical Outcomes in Metastatic Renal Cell Carcinoma.},
author = {Chen YW and Tucker MD and Brown LC and Yasin HA and Ancell KK and Armstrong AJ and Beckermann KE and Davis NB and Harrison MR and Kaiser EG and McAlister RK and Schaffer KR and Wallace DE and George DJ and Rathmell WK and Rini BI and Zhang T},
year = {2022},
journal = {Cancers},
doi = {10.3390/cancers14153830},
url = {https://doi.org/10.3390/cancers14153830}
}RIS
TY - JOUR TI - The Association between a Decrease in On-Treatment Neutrophil-to-Eosinophil Ratio (NER) at Week 6 after Ipilimumab Plus Nivolumab Initiation and Improved Clinical Outcomes in Metastatic Renal Cell Carcinoma. AU - Chen YW AU - Tucker MD AU - Brown LC AU - Yasin HA AU - Ancell KK AU - Armstrong AJ AU - Beckermann KE AU - Davis NB AU - Harrison MR AU - Kaiser EG AU - McAlister RK AU - Schaffer KR AU - Wallace DE AU - George DJ AU - Rathmell WK AU - Rini BI AU - Zhang T PY - 2022 JO - Cancers DO - 10.3390/cancers14153830 UR - https://doi.org/10.3390/cancers14153830 ER -
APA
YW, C., MD, T., LC, B., HA, Y., KK, A., AJ, A., KE, B., NB, D., MR, H., EG, K., RK, M., KR, S., DE, W., DJ, G., WK, R., BI, R., & T, Z. (2022). The Association between a Decrease in On-Treatment Neutrophil-to-Eosinophil Ratio (NER) at Week 6 after Ipilimumab Plus Nivolumab Initiation and Improved Clinical Outcomes in Metastatic Renal Cell Carcinoma.. Cancers. https://doi.org/10.3390/cancers14153830
Source records
- pubmed · retrieved 2026-09-27T07:00:18.039Z